ArticleBMJ open2023

Effects of empagliflozin on cardiac structure, function and biomarkers in patients with heart failure with preserved ejection fraction: study protocol for a randomised, placebo-controlled prospective trial.

Ke Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.